Sökning: id:"swepub:oai:gup.ub.gu.se/307550" >
Intralymphatic Glut...
Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial
-
- Ludvigsson, Johnny (författare)
- Linköpings universitet,Avdelningen för barns och kvinnors hälsa,Medicinska fakulteten,Region Östergötland, H.K.H. Kronprinsessan Victorias barn- och ungdomssjukhus
-
- Sumnik, Z. (författare)
- Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic,Charles Univ Prague, Czech Republic
-
- Pelikanova, T. (författare)
- Diabetes Centre of the Institute of Clinical and Experimental Medicine, Prague, Czech Republic,Inst Clin & Expt Med, Czech Republic
-
visa fler...
-
- Chavez, L. N. (författare)
- Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Madrid, Spain,Hosp Univ Ramon & Cajal, Spain
-
- Lundberg, Elena, 1961- (författare)
- Umeå universitet,Pediatrik,Umea Univ, Sweden
-
- Rica, I. (författare)
- Department of Pediatric Endocrinology, Cruces University Hospital, CIBERDEM, Bilbao, Spain,Cruces Univ Hosp, Spain
-
- Martinez-Brocca, M. A. (författare)
- Department of Endocrinology, Virgen Macarena Hospital, Sevilla, Spain,Virgen Macarena Hosp, Spain
-
- de Adana, M. R. (författare)
- Department of Adult Endocrinology and Diabetology, General University Hospital, Instituto de Biomedicina de Málaga, CIBERDEM, Malaga, Spain,Gen Univ Hosp, Spain
-
- Wahlberg, Jeanette, 1969- (författare)
- Linköpings universitet,Örebro universitet,Institutionen för medicinska vetenskaper,Departments of Endocrinology Region Östergötland and Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden,Medicinska fakulteten,Avdelningen för diagnostik och specialistmedicin,Region Östergötland, Endokrinmedicinska kliniken
-
- Katsarou, A. (författare)
- Department of Endocrinology, Skåne University Hospital, Malmö, Sweden,Skane Univ Hosp, Sweden
-
- Casas, Rosaura (författare)
- Linköpings universitet,Avdelningen för barns och kvinnors hälsa,Medicinska fakulteten
-
- Hernandez, C. (författare)
- Department of Endocrinology and Nutrition, Vall d’Hebron Hospital, CIBERDEM, Barcelona, Spain,Vall dHebron Hosp, Spain
-
- Leon, M. C. (författare)
- Department of Endocrinology and Nutrition, Vall d’Hebron Hospital, CIBERDEM, Barcelona, Spain,Vall dHebron Hosp, Spain
-
- Gomez-Gila, A. (författare)
- Pediatric Endocrinology Service, Virgen del Rocío University Hospital, Sevilla, Spain,Virgen Roc Univ Hosp, Spain
-
- Lind, Marcus, 1976 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden; Department of Medicine, Department of Medicine, Uddevalla, Sweden,Univ Gothenburg, Sweden; Dept Med, Sweden
-
- Lozano, M. F. (författare)
- Department of Pediatric Endocrinology, Miguel Servet University Hospital, Zaragoza, Spain,Miguel Servet Univ Hosp, Spain
-
- Sas, T. (författare)
- Diabeter, National Treatment and Research Center for Children, Adolescents and Young Adults With Type 1 Diabetes, and Department of Pediatric Endocrinology, Erasmus University Medical Center, Rotterdam, the Netherlands
-
- Samuelsson, Ulf, 1951- (författare)
- Linköpings universitet,Avdelningen för barns och kvinnors hälsa,Medicinska fakulteten,Region Östergötland, H.K.H. Kronprinsessan Victorias barn- och ungdomssjukhus
-
- Pruhova, S. (författare)
- Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic,Charles Univ Prague, Czech Republic; Motol Univ Hosp, Czech Republic
-
- Dietrich, Fabricia (författare)
- Linköpings universitet,Avdelningen för barns och kvinnors hälsa,Medicinska fakulteten
-
- Puente Marin, Sara (författare)
- Linköpings universitet,Avdelningen för barns och kvinnors hälsa,Medicinska fakulteten
-
- Nordlund, A. (författare)
- Trial Form Support, Lund, Sweden
-
- Hannelius, U. (författare)
- Diamyd Medical AB, Stockholm, Sweden,Diamyd Med AB, Sweden
-
Casas, R. (författare)
-
visa färre...
-
(creator_code:org_t)
- 2021-05-21
- 2021
- Engelska.
-
Ingår i: Diabetes Care. - : American Diabetes Association. - 0149-5992 .- 1935-5548. ; 44:7, s. 1604-1612
- Relaterad länk:
-
https://care.diabete...
-
visa fler...
-
https://doi.org/10.2...
-
https://gup.ub.gu.se...
-
https://doi.org/10.2...
-
https://urn.kb.se/re...
-
https://urn.kb.se/re...
-
https://urn.kb.se/re...
-
visa färre...
Abstract
Ämnesord
Stäng
- OBJECTIVE To evaluate the efficacy of aluminum-formulated intralymphatic glutamic acid decarboxylase (GAD-alum) therapy combined with vitamin D supplementation in preserving endogenous insulin secretion in all patients with type 1 diabetes (T1D) or in a genetically prespecified subgroup. RESEARCH DESIGN AND METHODS In a multicenter, randomized, placebo-controlled, double-blind trial, 109 patients aged 12-24 years (mean +/- SD 16.4 +/- 4.1) with a diabetes duration of 7-193 days (88.8 +/- 51.4), elevated serum GAD65 autoantibodies, and a fasting serum C-peptide >0.12 nmol/L were recruited. Participants were randomized to receive either three intralymphatic injections (1 month apart) with 4 mu g GAD-alum and oral vitamin D (2,000 IE daily for 120 days) or placebo. The primary outcome was the change in stimulated serum C-peptide (mean area under the curve [AUC] after a mixed-meal tolerance test) between baseline and 15 months. RESULTS Primary end point was not met in the full analysis set (treatment effect ratio 1.091 [CI 0.845-1.408]; P = 0.5009). However, GAD-alum-treated patients carrying HLA DR3-DQ2 (n = 29; defined as DRB1*03, DQB1*02:01) showed greater preservation of C-peptide AUC (treatment effect ratio 1.557 [CI 1.126-2.153]; P = 0.0078) after 15 months compared with individuals receiving placebo with the same genotype (n = 17). Several secondary end points showed supporting trends, and a positive effect was seen in partial remission (insulin dose-adjusted HbA(1c) <= 9; P = 0.0310). Minor transient injection site reactions were reported. CONCLUSION Intralymphatic administration of GAD-alum is a simple, well-tolerated treatment that together with vitamin D supplementation seems to preserve C-peptide in patients with recent-onset T1D carrying HLA DR3-DQ2. This constitutes a disease-modifying treatment for T1D with a precision medicine approach.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
Nyckelord
- beta-cell function
- excess mortality
- injection
- autoantigen
- children
- therapy
- insulin
- disease
- Endocrinology & Metabolism
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Ludvigsson, John ...
-
Sumnik, Z.
-
Pelikanova, T.
-
Chavez, L. N.
-
Lundberg, Elena, ...
-
Rica, I.
-
visa fler...
-
Martinez-Brocca, ...
-
de Adana, M. R.
-
Wahlberg, Jeanet ...
-
Katsarou, A.
-
Casas, Rosaura
-
Hernandez, C.
-
Leon, M. C.
-
Gomez-Gila, A.
-
Lind, Marcus, 19 ...
-
Lozano, M. F.
-
Sas, T.
-
Samuelsson, Ulf, ...
-
Pruhova, S.
-
Dietrich, Fabric ...
-
Puente Marin, Sa ...
-
Nordlund, A.
-
Hannelius, U.
-
Casas, R.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Endokrinologi oc ...
- Artiklar i publikationen
-
Diabetes Care
- Av lärosätet
-
Göteborgs universitet
-
Örebro universitet
-
Umeå universitet
-
Linköpings universitet